ZETIA (ezetimibe) is in a class of lipid-lowering compounds that selectively inhibits the intestinal absorption of cholesterol and related phytosterols. ZETIA is indicated for the following: Primary Hypercholesterolemia Monotherapy Ezetimibe, administered alone, is indicated as adjunctive therapy to diet for the reduction of elevated total-C, LDL-C, and Apo B in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. Combination therapy with HMG-CoA reductase inhibitors Ezetimibe, administered in combination with an HMG-CoA reductase inhibitor, is indicated as adjunctive therapy to diet for the reduction of elevated total-C, LDL-C, and Apo B in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. Homozygous Familial Hypercholesterolemia (HoFH) The combination of Ezetimibe and atorvastatin or simvastatin, is indicated for the reduction of elevated total-C and LDL-C levels in patients with HoFH, as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or if such treatments are unavailable. Homozygous Sitosterolemia Ezetimibe is indicated as adjunctive therapy to diet for the reduction of elevated sitosterol and campesterol levels in patients with homozygous familial sitosterolemia. Therapy with lipid-altering agents should be a component of multiple risk-factor intervention in individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Lipid-altering agents should be used in addition to an appropriate diet (including restriction of saturated fat and cholesterol) and when the response to diet and other non-pharmacological measures has been inadequate.
Active ingredients: Ezetimibe
advertisement
Compare prices at online shops
Strength
Quantity
Price, USD
Country
Canada Drug Center
10 mg
100
$71.00
Australia, Canada, India, Mauritius, NZ, Singapore, Turkey, UK, USA
Solaris Pharma Inc
10 mg
100
$85.00
Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
DoctorSolve Healthcare Solutions Inc.
10 mg
100
$34.00
Australia, Canada, India, NZ, Singapore, Turkey, UK, USA
BBG Fulfillment Ltd
10 mg
100
$43.00
Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
Dailymed."Ezetimibe: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
Can Ezetimibe be stopped immediately or do I have to stop the consumption gradually to ween off?
In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.
It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.
Can Ezetimibe be taken or consumed while pregnant?
Please visit your doctor for a recommendation as such case requires special attention.
Can Ezetimibe be taken for nursing mothers or during breastfeeding?
Kindly explain your state and condition to your doctor and seek medical advice from an expert.
advertisement
Reviews
Following the study conducted by gmedication.com on Ezetimibe, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Ezetimibe. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.
Patient reports
Patient reported useful
No survey data has been collected yet
Patient reported side effects
No survey data has been collected yet
Patient reported price estimates
No survey data has been collected yet
Patient reported frequency of use
No survey data has been collected yet
Patient reported doses
No survey data has been collected yet
Patient reported time for results
No survey data has been collected yet
Patient reported administration
No survey data has been collected yet
One patient reported age
Patients
%
46-60
1
100.0%
Patient reviews
There are no reviews yet. Be the first to write one!